Skip to main content

Security report for desitin.dk

Desitin Pharma A/S · Healthcare · Denmark

Medium risk. 3 critical or high findings in GDPR outside view, SSL/TLS and 1 other check.

Security score

63/100

Risk levelMedium

0–100, higher is better. How it is calculated

Desitin Pharma A/S is a well-established Danish pharmaceutical company founded in 1997, specializing in orphan drugs and treatments for central nervous system disorders. The company operates internationally with multiple country-specific domains, indicating a broad European presence. Their website is professionally designed using WordPress with modern technologies such as Bootstrap and Google Maps integration, providing a good user experience and clear navigation for both patients and healthcare professionals. Privacy and cookie policies are comprehensive and GDPR compliant, supported by a consent management system. Security posture is solid with HTTPS and cookie controls, though improvements like enabling DNSSEC and adding security headers are recommended. Overall, the website reflects a credible and trustworthy business with a medium-sized market position in healthcare.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

3 findings rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

  2. SSL/TLS

    TLS encrypts the connection and proves the site is really yours. Weak or expiring certificates trigger browser warnings and put traffic at risk.

    • High

      Weak Protocols Supported

      Server supports weak protocols: TLSv1.1

      What to do: Disable TLS 1.0, TLS 1.1, and all SSL versions

      • CWE-327
      • OWASP A04:2025
      • ASVS V12.1.1

  3. Network security

    Services reachable from the internet are the first thing attackers probe. Anything open that does not need to be should be closed.

    • High

      High-Risk Service Exposed: FTP

      Port 21 (FTP) is publicly accessible - FTP - Often unencrypted file transfer

      What to do: Consider restricting access to FTP or implementing strong authentication

      • NIS2 21(2)(e)
      • IR 2024/2690 6.7.2(f): Implementing Regulation (EU) 2024/2690, Annex point 6.7.2(f): Network security
      • NIST CM-7: NIST SP 800-53 Rev. 5 CM-7: Least Functionality
      • NIST SC-7: NIST SP 800-53 Rev. 5 SC-7: Boundary Protection

Need hands-on remediation? Email guard@offseq.com

Keep watching desitin.dk

This scan found 22 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
62
Security headers
80
Email security
85
DNS health
60
Network security
20
GDPR outside view
68
Average
63

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

The company targets healthcare professionals and patients, focusing on niche pharmaceutical products, particularly orphan drugs for CNS conditions. Their business model includes licensing agreements and product commercialization across multiple European markets. The presence of localized domains suggests a decentralized approach to market penetration. The website content and structure support professional communication and regulatory compliance, enhancing their competitive advantage. The lack of explicit incident response or security policy pages indicates an area for maturity growth. The company benefits from trust signals such as privacy compliance and consistent branding, positioning them well in the pharmaceutical sector.

Security posture

The website demonstrates a moderate to good security posture with enforced HTTPS, cookie consent management, and no visible sensitive data exposure. However, the absence of DNSSEC and security headers like Content-Security-Policy and X-Frame-Options represents potential vulnerabilities. No incident response contact or security policy is published, which could hinder rapid response to security events. The use of third-party scripts and plugins necessitates ongoing vulnerability management. Overall, the security measures are adequate for the business type but could be enhanced to meet higher standards and regulatory expectations.

Recommendations

  1. Enable DNSSEC on the domain to strengthen DNS security and prevent spoofing.
  2. Implement standard security headers such as Content-Security-Policy, X-Frame-Options, and Strict-Transport-Security.
  3. Publish a dedicated security policy and provide incident response contact information to improve transparency and readiness.
  4. Regularly audit and update third-party plugins and scripts to mitigate vulnerabilities.
  5. Enhance accessibility features to improve compliance and user experience for all visitors.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Desitin Pharma A/S
Description
Desitin Pharma A/S is a pharmaceutical company operating in Europe, specializing in orphan drugs and treatments related to central nervous system diseases such as epilepsy and psychiatry. They have international presence with subsidiaries or related sites in multiple European countries.
Key services
Pharmaceutical product commercialization, Orphan drug licensing, Healthcare professional support
Content quality
good
Branding
consistent

Technology

Stack
WordPress, Yoast SEO plugin, jQuery, Bootstrap, Google Maps API, Borlabs Cookie plugin
Frameworks
Bootstrap
Platforms
WordPress
Performance
moderate
Mobile
good
Accessibility
basic
SEO
good

Security

Observed score
75/100
Good practices seen
  • HTTPS enforced
  • Cookie consent with granular controls
  • No exposed sensitive data in HTML

Analytics and tracking

Services
Google Analytics
Tracking level
moderate
Privacy practices
good

Advertising

Marketing tools
Borlabs Cookie
Transparency
good

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is a professional pharmaceutical company site with multi-country presence
  2. Uses WordPress CMS with common plugins for SEO and cookie management
  3. Has GDPR compliant privacy and cookie policies with consent mechanisms
  4. No visible security policy or incident response information
  5. No DNSSEC enabled which is a minor security gap
  6. No suspicious or malicious content detected
  7. Good use of HTTPS and modern web technologies
  8. Contact information is present but no explicit email addresses found in HTML
  9. Multiple external domains linked mainly for international subsidiaries and social media
Technical notes

Notes

The website is built on WordPress CMS with a modern tech stack including Bootstrap for responsive design and jQuery for scripting. SEO is enhanced via Yoast SEO plugin, and cookie management is handled by Borlabs Cookie plugin, ensuring GDPR compliance. Performance is moderate with preloaded fonts and asynchronous script loading. The site is mobile optimized and uses Google Maps API for location services. Hosting appears stable with A/S SCANNET as registrar. Technical debt is low, but security enhancements and accessibility improvements are recommended to future-proof the platform.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with desitin.dk. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review desitin.dk.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.